Zimmer Biomet (ZBH) Acquires Monogram Technologies to Expand AI-Driven Orthopedic Robotics Portfolio

Core Insights - Zimmer Biomet Holdings Inc. (NYSE:ZBH) has successfully acquired Monogram Technologies Inc., an AI-driven orthopedic robotics firm, for approximately $177 million, enhancing its orthopedic solution offerings [1] - The company’s technology portfolio includes the ROSA Robotics platform, which has nearly 2,000 installations worldwide, and it continues to develop this platform post-acquisition [2] - Zimmer Biomet is focused on launching new products, including the ROSA Knee with OptimiZe, which is currently pending FDA approval, with expectations for releases between this year and 2027 [2][3] Company Overview - Zimmer Biomet Holdings Inc. is a global medical technology company that specializes in designing, developing, manufacturing, and marketing orthopedic products, including implants and robotic solutions [3]